Osteogenic commitment of Wharton’s jelly mesenchymal stromal cells: mechanisms and implications for bioprocess development and clinical application

Raquel Cabrera-Pérez(Vall d'Hebron Institut de Recerca), Joaquim Vives(Universitat Autònoma de Barcelona)

Stem Cell Research & Therapy

November 28, 2019

10.1186/s13287-019-1450-3

Cited by 34

Related Papers

Comparability exercise of critical quality attributes of clinical-grade human mesenchymal stromal cells from the Wharton’s jelly: single-use stirred tank bioreactors versus planar culture systems

|Cytotherapy|2023|9

Human Wharton’s jelly-derived mesenchymal stromal cells promote bone formation in immunodeficient mice when administered into a bone microenvironment

|Journal of Translational Medicine|2023|4